Skip to main content
Log in

Development and in-house validation of an allergen-specific ELISA for quantification of Bet v 4 in diagnostic and therapeutic birch allergen products

  • Research Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

Birch (Betula) pollen is a major cause of allergy in northern and central Europe. The allergenic potency of products for diagnosis and therapy of birch pollen allergy is adjusted nearly exclusively to the major birch pollen allergen Bet v 1. Although every fifth patient is additionally sensitized to Bet v 4, both content and variability of this minor allergen in birch allergen products remain unclear due to a lack of simple and cost-effective quantitative methods. This study aimed to develop and in-house validate the first Bet v 4-specific sandwich enzyme-linked immunosorbent assay (ELISA). Based on a murine monoclonal antibody in combination with a polyclonal rabbit antiserum, the ELISA proved to be highly sensitive, with a lower limit of quantification of 30 pg/ml Bet v 4. After confirmation of satisfactory accuracy, reproducibility, and robustness, the ELISA was utilized to quantify Bet v 4 in 30 authorized birch allergen products. The allergen was detected in all samples tested, ranging from 0.2 to 4.4 μg/ml. No significant correlation of Bet v 4 was found with the respective amount of Bet v 1. In contrast to Bet v 1, also no correlation of Bet v 4 with total protein content or total allergenic activity could be observed. Thus, it seems presently unfeasible to base birch allergen product standardization additionally on Bet v 4. In light of these results, the continuous monitoring of Bet v 4 in birch allergen products with the presented ELISA will provide a basis for the understanding of the clinical relevance of minor allergens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

AIT:

Allergen immunotherapy

Bet v:

Birch allergen (Betula verrucosa, nomenclature according to the International Union of Immunological Societies)

ELISA:

Enzyme-linked immunosorbent assay

mAb:

Monoclonal antibody

MS:

Mass spectrometry

nBet v:

Native birch allergen

PTS:

Prick test solution

rBet v:

Recombinant birch allergen

SLIT:

Sublingual immunotherapy

TMB:

3,3′,5,5′-Tetramethylbenzidine

References

  1. Akkerdaas JH, Wensing M, Knulst AC, Krebitz M, Breiteneder H, de Vries S, Penninks AH, Aalberse RC, Hefle SL, van Ree R (2003) How accurate and safe is the diagnosis of hazelnut allergy by means of commercial skin prick test reagents? Int Arch Allergy Immunol 132(2):132–140

    Article  CAS  Google Scholar 

  2. Focke M, Marth K, Valenta R (2009) Molecular composition and biological activity of commercial birch pollen allergen extracts. Eur J Clin Investig 39(5):429–436

    Article  CAS  Google Scholar 

  3. Focke M, Marth K, Flicker S, Valenta R (2008) Heterogeneity of commercial timothy grass pollen extracts. Clin Exp Allergy 38(8):1400–1408

    Article  CAS  Google Scholar 

  4. Kaul S, Luttkopf D, Kastner B, Vogel L, Holtz G, Vieths S, Hoffmann A (2007) Mediator release assays based on human or murine immunoglobulin E in allergen standardization. Clin Exp Allergy 37(1):141–150

    Article  CAS  Google Scholar 

  5. van Ree R (1997) Monoclonal versus monospecific polyclonal antibodies and purified major allergens: their application in allergen standardization. Arb.Paul Ehrlich Inst.Bundesamt Sera Impfstoffe Frankf A M. 91:174–176

  6. (2007) CHMP: guideline on allergen products: production and quality issues, EMEA/CHMP/BWP/304831/2007

  7. (2010) Allergen products, general monographs. In: European pharmacopoeia, 6.6 und 7.3, Strasbourg, France: Council of Europe, pp 6903–6906 und 5541–5544

  8. Arilla MC, Ibarrola I, Garcia R, de La Hoz B, Martinez A, Asturias JA (2004) Quantification of the major allergen from cypress (Cupressus arizonica) pollen, Cup a 1, by monoclonal antibody-based ELISA. Int Arch Allergy Immunol 134(1):10–16

    Article  CAS  Google Scholar 

  9. Asturias JA, Arilla MC, Aguirre M, Gomez-Bayon N, Martinez A, Palacios R, Sanchez-Gascon F, Martinez J (1999) Quantification of profilins by a monoclonal antibody-based sandwich ELISA. J Immunol Methods 229(1–2):61–71

    Article  CAS  Google Scholar 

  10. Arilla MC, Eraso E, Ibarrola I, Algorta J, Martinez A, Asturias JA (2002) Monoclonal antibody-based method for measuring olive pollen major allergen Ole e 1. Ann Allergy Asthma Immunol 89(1):83–89

    Article  CAS  Google Scholar 

  11. Duffort O, Calabozo B, Gonzalez R, Carpizo JA, Barber D, Polo F (2004) Monoclonal antibody-based ELISA to quantify the major allergen of Cynodon dactylon (Bermuda grass) pollen, Cyn d 1. Int Arch Allergy Immunol 135(4):277–283

    Article  CAS  Google Scholar 

  12. Jimeno L, Duffort O, Serrano C, Barber D, Polo F (2004) Monoclonal antibody-based ELISA to quantify the major allergen of Artemisia vulgaris pollen, Art v 1. Allergy 59(9):995–1001

    Article  CAS  Google Scholar 

  13. Ramirez J, Carpizo JA, Ipsen H, Carreira J, Lombardero M (1997) Quantification in mass units of Bet v 1, the main allergen of Betula verrucosa pollen, by a monoclonal antibody based-ELISA. Clin Exp Allergy 27(8):926–931

    Article  CAS  Google Scholar 

  14. Seppala U, Dauly C, Robinson S, Hornshaw M, Larsen JN, Ipsen H (2011) Absolute quantification of allergens from complex mixtures: a new sensitive tool for standardization of allergen extracts for specific immunotherapy. J Proteome Res 10(4):2113–2122

    Article  CAS  Google Scholar 

  15. Erler A, Hawranek T, Kruckemeier L, Asam C, Egger M, Ferreira F, Briza P (2011) Proteomic profiling of birch (Betula verrucosa) pollen extracts from different origins. Proteomics 11(8):1486–1498

    Article  CAS  Google Scholar 

  16. Engel E, Richter K, Obermeyer G, Briza P, Kungl AJ, Simon B, Auer M, Ebner C, Rheinberger HJ, Breitenbach M, Ferreira F (1997) Immunological and biological properties of Bet v 4, a novel birch pollen allergen with two EF-hand calcium-binding domains. J Biol Chem 272(45):28630–28637

    Article  CAS  Google Scholar 

  17. Twardosz A, Hayek B, Seiberler S, Vangelista L, Elfman L, Gronlund H, Kraft D, Valenta R (1997) Molecular characterization, expression in Escherichia coli, and epitope analysis of a two EF-hand calcium-binding birch pollen allergen, Bet v 4. Biochem Biophys Res Commun 239(1):197–204

    Article  CAS  Google Scholar 

  18. Moverare R, Westritschnig K, Svensson M, Hayek B, Bende M, Pauli G, Sorva R, Haahtela T, Valenta R, Elfman L (2002) Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: an imprint of local sensitization. Int Arch Allergy Immunol 128(4):325–335

    Article  CAS  Google Scholar 

  19. Sekerkova A, Polackova M (2011) Detection of Bet v1, Bet v2 and Bet v4 specific IgE antibodies in the sera of children and adult patients allergic to birch pollen: evaluation of different IgE reactivity profiles depending on age and local sensitization. Int Arch Allergy Immunol 154(4):278–285

    Article  CAS  Google Scholar 

  20. Rossi RE, Monasterolo G, Monasterolo S (2003) Detection of specific IgE antibodies in the sera of patients allergic to birch pollen using recombinant allergens Bet v 1, Bet v 2, Bet v 4: evaluation of different IgE reactivity profiles. Allergy 58(9):929–932

    Article  CAS  Google Scholar 

  21. Foetisch K, Dahl L, Jansen B, Becker WM, Lidholm J, van Ree R, Broll H, Kaul S, Vieths S, Holzhauser T (2011) Development and in-house validation of allergen-specific ELISA tests for the quantification of Dau c 1.01, Dau c 1.02 and Dau c 4 in carrot extracts (Daucus carota). Anal Bioanal Chem 399(2):935–943

    Article  CAS  Google Scholar 

  22. Wopfner N, Gruber P, Wallner M, Briza P, Ebner C, Mari A, Richter K, Vogel L, Ferreira F (2008) Molecular and immunological characterization of novel weed pollen pan-allergens. Allergy 63(7):872–881

    Article  CAS  Google Scholar 

  23. Ledesma A, Villalba M, Batanero E, Rodriguez R (1998) Molecular cloning and expression of active Ole e 3, a major allergen from olive-tree pollen and member of a novel family of Ca2+-binding proteins (polcalcins) involved in allergy. Eur J Biochem 258(2):454–459

    Article  CAS  Google Scholar 

  24. Suphioglu C, Ferreira F, Knox RB (1997) Molecular cloning and immunological characterisation of Cyn d 7, a novel calcium-binding allergen from Bermuda grass pollen. FEBS Lett 402(2–3):167–172

    Article  CAS  Google Scholar 

  25. Barber D, de La Torre F, Feo F, Florido F, Guardia P, Moreno C, Quiralte J, Lombardero M, Villalba M, Salcedo G, Rodriguez R (2008) Understanding patient sensitization profiles in complex pollen areas: a molecular epidemiological study. Allergy 63(11):1550–1558

    Article  CAS  Google Scholar 

  26. Mari A (2001) Multiple pollen sensitization: a molecular approach to the diagnosis. Int Arch Allergy Immunol 125(1):57–65

    Article  CAS  Google Scholar 

  27. Hauser M, Roulias A, Ferreira F, Egger M (2010) Panallergens and their impact on the allergic patient. Allergy Asthma Clin Immunol 6(1):1

    Article  Google Scholar 

  28. Tinghino R, Twardosz A, Barletta B, Puggioni EM, Iacovacci P, Butteroni C, Afferni C, Mari A, Hayek B, Di FG, Focke M, Westritschnig K, Valenta R, Pini C (2002) Molecular, structural, and immunologic relationships between different families of recombinant calcium-binding pollen allergens. J Allergy Clin Immunol 109(2):314–320

    Article  CAS  Google Scholar 

  29. Burrows B, Bloom JW, Traver GA, Cline MG (1987) The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 317(21):1309–1314

    Article  CAS  Google Scholar 

  30. Neudecker P, Nerkamp J, Eisenmann A, Nourse A, Lauber T, Schweimer K, Lehmann K, Schwarzinger S, Ferreira F, Rosch P (2004) Solution structure, dynamics, and hydrodynamics of the calcium-bound cross-reactive birch pollen allergen Bet v 4 reveal a canonical monomeric two EF-hand assembly with a regulatory function. J Mol Biol 336(5):1141–1157

    Article  CAS  Google Scholar 

  31. Karamloo F, Wangorsch A, Kasahara H, Davin LB, Haustein D, Lewis NG, Vieths S (2001) Phenylcoumaran benzylic ether and isoflavonoid reductases are a new class of cross-reactive allergens in birch pollen, fruits and vegetables. Eur J Biochem 268(20):5310–5320

    Article  CAS  Google Scholar 

  32. Cadot P, Nelles L, Srahna M, Dilissen E, Ceuppens JL (2006) Cloning and expression of the cyclophilin Bet v 7, and analysis of immunological cross-reactivity among the cyclophilin A family. Mol Immunol 43(3):226–235

    Article  CAS  Google Scholar 

  33. Reese G, Ballmer-Weber BK, Wangorsch A, Randow S, Vieths S (2007) Allergenicity and antigenicity of wild-type and mutant, monomeric, and dimeric carrot major allergen Dau c 1: destruction of conformation, not oligomerization, is the roadmap to save allergen vaccines. J Allergy Clin Immunol 119(4):944–951

    Article  CAS  Google Scholar 

  34. Schagger H, von Jagow G (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166(2):368–379

    Article  CAS  Google Scholar 

  35. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal.Biochem. 72(0003–2697 (Linking)):248–254

  36. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) (2005) ICH-Guideline Q2 (R1) Validation of analytical procedures: text and methodology. http://www.ich.org

  37. European Pharmacopoeia (2008) Statistical Analysis of Results of Biological Assays and Tests. Strasbourg, France, Council of Europe. Ph. Eur. 8th edn, pp 607–635

  38. Food and Drug Administration, Center for Drug Evaluation and Research (2001) Guidance for industry: bioanalytical method validation

  39. Wild D (2005) The immunoassay handbook. Elsevier Ltd, Oxford

  40. Nič M, Jirát J, Košata B, Jenkins A, McNaught A (eds) (2009) IUPAC compendium of chemical terminology. IUPAC, Research Triangle Park, NC

    Google Scholar 

  41. European Medicines Agency (2011) Guideline on bioanalytical method validation

  42. Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Stat 6(2):65–70

    Google Scholar 

  43. R Core Team (2014) R: a Language and Environment for Statistical Computing. R Foundation for Statistical Computing. Vienna, Austria

  44. Reuter A, Luttkopf D, Vieths S (2009) New frontiers in allergen standardization. Clin Exp Allergy 39(3):307–309

    Article  CAS  Google Scholar 

  45. Carnes J, Himly M, Gallego M, Iraola V, Robinson DS, Fernandez-Caldas E, Briza P (2009) Detection of allergen composition and in vivo immunogenicity of depigmented allergoids of Betula alba. Clin Exp Allergy 39(3):426–434

    Article  CAS  Google Scholar 

  46. Neske F, Schorner C, Buchheit KH, Costanzo A, Hanschmann KM, Himly M, Holzhauser T, Ferreira F, Kaul S, Vieths S, van RR (2009) BSP090—the follow-up to CREATE. Arb.Paul Ehrlich Inst.Bundesamt Sera Impfstoffe Frankf A M. 96(0936–8671 (Linking)):12–19

  47. Vieths S, Kaul S, Hanschmann KM, Schorner C, Barber D, Ledesma A, Chapman M, Hrabina M, Moingeon P, Fiebig H, Reese G, Weber B, van RR, Buchheit KH, Costanzo A (2012) Establishment of recombinant major allergens Bet v 1 and Phl p 5a as Ph. Eur. reference standards and validation of ELISA methods for their measurement. Results from feasibility studies. Pharmeur.Bio Sci.Notes 2012(2075–2164 (Linking)):118–134

  48. van Ree R, Chapman MD, Ferreira F, Vieths S, Bryan D, Cromwell O, Villalba M, Durham SR, Becker WM, Aalbers M, Andre C, Barber D, Cistero BA, Custovic A, Didierlaurent A, Dolman C, Dorpema JW, Di FG, Eberhardt F, Fernandez CE, Fernandez RM, Fiebig H, Focke M, Fotisch K, Gadermaier G, Das RG, Gonzalez ME, Himly M, Kinaciyan T, Knulst AC, Kroon AM, Lepp U, Marco FM, Mari A, Moingeon P, Monsalve R, Neubauer A, Notten S, Ooievaar-de HP, Pauli G, Pini C, Purohit A, Quiralte J, Rak S, Raulf-Heimsoth M, San Miguel Moncin MM, Simpson B, Tsay A, Vailes L, Wallner M, Weber B (2008) The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification. Allergy 63(3):310–326

    Article  Google Scholar 

  49. Mahler V, Fischer S, Heiss S, Duchene M, Kraft D, Valenta R (2001) cDna cloning and characterization of a cross-reactive birch pollen allergen: identification as a pectin esterase. Int Arch Allergy Immunol 124(1–3):64–66

    Article  CAS  Google Scholar 

  50. Esch RE (1997) Allergen source materials and quality control of allergenic extracts. Methods 13(1):2–13

    Article  CAS  Google Scholar 

  51. Castro AJ, de Dios AJ, Cuevas J, Romero PJ, Alche V, Rodriguez-Garcia MI (2003) Pollen from different olive tree cultivars contains varying amounts of the major allergen Ole e 1. Int Arch Allergy Immunol 131(3):164–173

    Article  CAS  Google Scholar 

  52. Hayek B, Vangelista L, Pastore A, Sperr WR, Valent P, Vrtala S, Niederberger V, Twardosz A, Kraft D, Valenta R (1998) Molecular and immunologic characterization of a highly cross-reactive two EF-hand calcium-binding alder pollen allergen, Aln g 4: structural basis for calcium-modulated IgE recognition. J Immunol 161(12):7031–7039

    CAS  Google Scholar 

  53. Casset A, Mari A, Purohit A, Resch Y, Weghofer M, Ferrara R, Thomas WR, Alessandri C, Chen KW, de Blay F, Valenta R, Vrtala S (2012) Varying allergen composition and content affects the in vivo allergenic activity of commercial Dermatophagoides pteronyssinus extracts. Int Arch Allergy Immunol 159(3):253–262

    Article  CAS  Google Scholar 

  54. Eichler I, Gotz M, Jarisch R, Eichler HG, Moss R (1988) Reproducibility of skin prick testing with allergen extracts from different manufacturers. Allergy 43(6):458–463

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This study was realized thanks to the support of ALK-Abelló Arzneimittel GmbH, Allergopharma GmbH & Co. KG, Bencard Allergie GmbH, HAL Allergy GmbH, Leti Pharma GmbH, Stallergenes GmbH (listed in alphabetical order), and their representatives, giving consent for the use of their birch pollen extracts designated for batch release control at the PEI. Many thanks go to Prof. Dr. Paul Rösch, University of Bayreuth, Germany, for providing the recombinant Bet v 4.

Conflict of interest

In the past 5 years, Stefan Vieths has received a speaker’s honorarium from Phadia (now Thermo Fisher Scientific), Uppsala; an honorarium for organizing and chairing an educational seminar on food allergens from Fresenius Academy, Dortmund; honoraria for acting as expert reviewer for the Allergen Online Database of the Food Allergy Resource and Research Program, Lincoln NE; and consultancy fees by the Institute for Product Quality, Berlin.

Thomas Holzhauser had consultant arrangements with Institut für Produktqualität and Monsanto Company. He received fees from Die Akademie Fresenius for speaking and organizing education. He received reimbursement for lectures from the European Academy of Allergology and Clinical Immunology, World Allergy Organization, Deutscher Allergie- und Asthmabund e.V., International Life Sciences Institute/Health and Environmental Sciences Institute, International Association for Food Protection, AOAC International, Chinesisch-Deutsches Zentrum für Wissenschaftsförderung, Phadia AB, and SAG Süderelbe Projektgesellschaft AG & Co. KG.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Susanne Kaul.

Additional information

Oliver Dehus and Julia Zimmer contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dehus, O., Zimmer, J., Döring, S. et al. Development and in-house validation of an allergen-specific ELISA for quantification of Bet v 4 in diagnostic and therapeutic birch allergen products. Anal Bioanal Chem 407, 1673–1683 (2015). https://doi.org/10.1007/s00216-014-8418-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-014-8418-z

Keywords

Navigation